David de Wied

Q: What Schools Are Affiliated With David de Wied

David de Wied is affiliated with the following schools: Utrecht University, University of Groningen

David de Wied's AcademicInfluence.com Rankings

David de Wied

Medical

#462

World Rank

#633

Historical Rank

Pharmacology

#32

World Rank

#41

Historical Rank

medical Degrees

Download Badge

Medical

Why Is David de Wied Influential?

(Suggest an Edit or Addition)

According to Wikipedia, David de Wied was a Dutch professor of pharmacology at the University of Utrecht. Due to the necessity of hiding as a Jew during the Second World War, De Wied only started in 1947 studying medicine at the University of Groningen. In 1952 he received his PhD with his thesis "Vitamin C, Adrenal gland and Adaptation" and in 1955 he graduated as physician. In 1961 he was appointed professor of experimental endocrinology and from 1963 he served as director of the Rudolf Magnus Institute and professor of pharmacology in Utrecht.

(See a Problem?)

David de Wied's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Long Term Effect of Vasopressin on the Maintenance of a Conditioned Avoidance Response in Rats (1971) (441)
Effect of oxytocin and vasopressin on memory consolidation: sites of action and catecholaminergic correlates after local microinjection into limbic-midbrain structures (1979) (339)
Behavioral effects of intraventricularly administered vasopressin and vasopressin fragments (1976) (335)
Central Nervous System Effects of the Neurohypophyseal Hormones and Related Peptides (1993) (320)
Oxytocin, vasopressin and memory: opposite effects on consolidation and retrieval processes (1978) (317)
Plasma Levels of Arginine Vasopressin Elevated in Patients with Major Depression (1997) (306)
Neuroleptic activity of the neuropeptide β-LPH62–77 ([Des-Tyr1]γ-endorphin; DTγE) (1978) (287)
Neuropeptides, food intake and body weight regulation: a hypothalamic focus (2002) (273)
Long Term and Short Term Effects on Retention of a Conditioned Avoidance Response in Rats by Treatment with Long Acting Pitressin and α-MSH (1966) (245)
Central target for the behavioural effects of vasopressin neuropeptides (1984) (244)
Inhibitory Effect of ACTH and Related Peptides on Extinction of Conditioned Avoidance Behavior in Rats (1966) (243)
Opposite effects of oxytocin and vasopressin on avoidance behaviour and hippocampal theta rhythm in the rat (1978) (228)
Memory deficit in rats with hereditary diabetes insipidus (1975) (227)
Peptides and behavior. (1977) (226)
Pituitary adrenal system hormones and behaviour. (1977) (204)
Behaviourably active ACTH analogues (1975) (193)
INFLUENCE OF ANTERIOR PITUITARY ON AVOIDANCE LEARNING AND ESCAPE BEHAVIOR. (1964) (183)
Behavioral effects of peptides (1977) (182)
Improvement of Schizophrenic Patients Treated With Des-Tyr1]-γ-endorphin (DTγE) (1979) (182)
Dissociation of the behavioural and endocrine effects of lysine vasopressin by tryptic digestion (1972) (170)
Behavioral and endocrine responses of rats with hereditary hypothalamic diabetes insipidus (Brattleboro strain) (1975) (166)
Effects of lysine vasopressin on passive avoidance learning (1972) (154)
Induction of excessive grooming in the rat by fragments of lipotropin (1976) (140)
Selective conversion of β-endorphin into peptides related to γ- and α-endorphin (1980) (123)
Barrel rotation induced by vasopressin and related peptides in rats (1977) (120)
Prolyl-leucyl-glycinamide (PLG) facilitates morphine dependence (1976) (116)
Disrupting circadian rhythms in rats induces retrograde amnesia (1985) (116)
Vasopressin and memory (1983) (115)
Differential behavioral actions of corticotropin-releasing factor (CRF) (1984) (113)
Effects of systemic and intracerebral administration of two opposite acting ACTH-related peptides on extinction of conditioned avoidance behavior. (1971) (106)
Neuroleptic-like activity of peptides related to [DES-TYR1] ?-endorphin: Structure activity studies (1980) (102)
Induction of tolerance to the analgesic action of lipotropin C-Fragment (1976) (102)
The site of the suppressive action of dexamethasone on pituitary-adrenal activity. (1974) (99)
Testosterone-sensitive vasotocin-immunoreactive cells and fibers in the canary brain (1988) (91)
The Role of the CRH Type 1 Receptor in Autonomic Responses to Corticotropin-Releasing Hormone in the Rat (2000) (86)
Modulation of passive-avoidance behavior of rats by intracerebroventricular administration of antivasopressin serum. (1976) (86)
CRH Signalling in the Bed Nucleus of the Stria Terminalis is Involved in Stress-Induced Cardiac Vagal Activation in Conscious Rats (2001) (85)
ACTH-like peptides and morphine: interaction at the level of the CNS (1977) (83)
Regional effects of vasopressin on rat brain catecholamine metabolism (1977) (82)
CHLORPROMAZINE AND ENDOCRINE FUNCTION (1967) (79)
Neuropeptides, mental performance and aging (1982) (77)
BHAVIORAL EFFECTS OF NEUROPEPTIDES RELATED TO ACTH, MSH, AND βLPH (1977) (77)
Dorsal hippocampus: A site of action of neuropeptides on avoidance behavior? (1976) (77)
Beneficial effect of chronic treatment with Org 2766 and α-MSH on impaired reversal learning of rats with bilateral lesions of the parafascicular area (1985) (77)
Plasma arginine vasopressin and motor activity in major depression (1998) (76)
Vasopressin modulates the activity of catecholamine containing neurons in specific brain regions (1979) (75)
Modulation of heroin self-administration by neurohypophyseal principles. (1977) (74)
Neuropeptides: Effects on paradoxical sleep and theta rhythm in rats (1978) (74)
CNS Sites of Action of ACTH, MSH and Vasopressin in Relation to Avoidance Behavior (1975) (72)
Facilitation of avoidance behavior by vasopressin fragments microinjected into limbic-midbrain structures (1986) (72)
Central actions of neurohypophysial hormones. (1983) (69)
Drug Effects and Hypothalamic-Anterior Pituitary Function (1974) (68)
Effect of a vasotocin analog on singing behavior in the canary (1991) (68)
Behavioral profile of γ MSH: Relationship with ACTH and ß endorphin action (1981) (67)
Behavioural Actions of Neurohypophysial Peptides (1980) (66)
α-Endorphin, γ-endorphin and their Des tyrosine fragments in rat pituitary and brain tissue (1980) (66)
Central effects of angiotensins on drinking and blood pressure: Structure-activity relationships (1982) (64)
CHAPTER 3 – Actions of ACTH- and MSH-like Peptides on Learning, Performance, and Retention (1981) (63)
Hormones and the Brain (1980) (63)
An inhibitory role of β-endorphin in central cardiovascular regulation (1982) (61)
Heroin self-administration is under control of vasopressin. (1977) (61)
Failure of α-MSH to delay extinction of conditioned avoidance behavior in rats with lesions in the parafascicular nuclei of the thalamus (1967) (57)
Schizophrenia as an inborn error in the degradation of β-endorphin — a hypothesis (1979) (57)
Potency and duration of action of the ACTH 4–9 analog (ORG 2766) as compared to ACTH 4–10 and [D-Phe7] ACTH 4–10 on active and passive avoidance behavior of rats (1982) (57)
The importance of vasopressin in memory (1984) (55)
Effects of [Des-Tyr1]-γ-endorphin and α-endorphin on substantia nigra self-stimulation (1979) (55)
Involvement of neurohypophyseal peptides in drug-mediated adaptive responses (1980) (53)
Vasopressin maintains long-term potentiation in rat lateral septum slices (1989) (53)
Effects of α-endorphin, β-endorphin and (des-tyr1)-γ-endorphin on α-MPT-induced catecholamine disappearance in discrete regions of the rat brain (1979) (50)
Substances resembling C-terminal vasopressin fragments are present in the brain but not in the pituitary gland (1984) (50)
Neuropeptides in learning and memory processes (1997) (50)
Oxytocin biotransformation in the rat limbic brain: Characterization of peptidase activities and significance in the formation of oxytocin fragments (1980) (49)
Sites of behavioral and neurochemical action of ACTH-like peptides and neurohypophyseal hormones (1983) (48)
THE SITE OF THE BLOCKING ACTION OF DEXAMETHASONE ON STRESS-INDUCED PITUITARY ACTH RELEASE. (1964) (48)
Autoradiographic localization of binding sites for the arginine-vasopressin (VP) metabolite, VP4–9, in rat brain (1985) (48)
Antipsychotic Properties of Des-Enkephalin-γ-Endorphin in Treatment of Schizophrenic Patients (1982) (45)
Vasopressin and related peptides: Animal and human studies (1985) (45)
Specific uptake of a behaviorally potent [3H]ACTH4–9 analog in the septal area after intraventricular injection in rats (1977) (45)
Neuropeptides involved in the pathophysiology of schizophrenia and major depression (2009) (43)
SIMILARITY BETWEEN BEHAVIORAL EFFECTS OF DES-TYROSINE-γ-ENDORPHIN AND HALOPERIDOL AND OF α-ENDORPHIN AND AMPHETAMINE (1980) (42)
Non-opiate β-endorphin fragments and dopamine—I the neuroleptic-like γ-endorphin fragments interfere with the behavioural effects elicited by small doses of apomorphine (1982) (42)
Effect of neonatally injected ACTH and ACTH analogues on eye-opening of the rat. (1976) (41)
In vivo conversion of vasopressin after microinjection into limbic brain areas of rats (1989) (41)
Behavioral effects of Org 2766, a synthetic analog of the adrenocorticotrophic hormone (4–9), in 14 outpatient autistic children (1990) (40)
The effects of pregnenolone sulfate and ethylestrenol on retention of a passive avoidance task (1995) (40)
Prolyl-leucyl-glycinamide (PLG); regional effects on α-MPT-induced catecholamine disappearance in rat brain (1978) (40)
Neuroleptic-like profile of γ-type endorphins as related to schizophrenia (1982) (40)
Sexual dimorphism in passive avoidance behavior of rats: Relation to body weight, age, shock intensity and retention interval (1980) (39)
Effect of neurohypophyseal hormones on morphine dependence (1977) (39)
The effect of corticotropin-releasing factor (CRF) on autonomic and behavioral responses during shock-prod burying test in rats (1992) (39)
SCHIZOPHRENIA AND DEGRADATION OF ENDORPHINS IN CEREBROSPINAL FLUID (1979) (38)
Vasopressin antagonists block peripheral as well as central vasopressin receptors (1984) (38)
Prolactin-enhanced grooming behavior: Interaction with ACTH (1983) (38)
A frequency shift in the hippocampal theta activity: an electrical correlate of central action of ACTH analogues in the dog? (1974) (37)
Differential responses in immunoreactive arginine-vasopressin content of microdissected brain regions during passive avoidance behavior (1983) (37)
The effect of ACTH-analogues on motor behavior and visual evoked responses in rats (1976) (37)
Pituitary, adrenal and the brain (1970) (37)
Cardiovascular effects of substance P and capsaicin microinjected into the nucleus tractus solitarii of the rat (1987) (37)
Inferior quality of RSA during paradoxical sleep in rats with hereditary diabetes insipidus (1975) (36)
Arginine-vasopressin content of hippocampus and amygdala during passive avoidance behavior in rats (1983) (35)
Regional distribution of α- and γ-type endorphins in rat brain (1982) (35)
Proconvulsive effect of vasopressin; mediation by a putative V2 receptor subtype in the central nervous system (1997) (35)
Behavioral pharmacology of neuropeptides related to melanocortins and the neurohypophyseal hormones. (1999) (35)
Central actions of ACTH and related peptides (1986) (35)
Endorphinergic mechanisms in cerebral blood flow autoregulation (1986) (35)
Modulation of ACTH-induced grooming by [DES-TYR1]-γ-endorphin and haloperidol (1980) (34)
Chapter 9 The neuropeptide concept (1987) (34)
Long-lasting enhancement of synaptic excitability of CA1/subiculum neurons of the rat ventral hippocampus by vasopressin and vasopressin(4–8) (1995) (33)
Pituitary peptides and memory (1975) (32)
Effects of intracerebral implantation of corticosteroids on extinction of an avoidance response in rats (1969) (31)
Structure‐Activity Studies on the Neuroactive and Neurotropic Effects of Neuropeptides Related to ACTH (1988) (31)
Dose-related facilitation and inhibition of passive avoidance behavior by the ACTH 4-9 Analog (ORG 2766) (1982) (31)
THE USE OF THE SYNTHETIC PEPTIDES γ‐TYPE ENDORPHINS IN MENTALLY ILL PATIENTS (1982) (30)
Increased concentration of α- and γ-endorphin in post mortem hypothalamic tissue of schizophrenic patients (1988) (29)
Effect of Autonomic Blocking Agents and Structurally Related Substances on the "Salt Arousal of Drinking'" (1966) (29)
The distribution and plasticity of [3H]vasopressin-labelled specific binding sites in the canary brain (1988) (29)
Weak 24-h periodicity of body temperature and increased plasma vasopressin in melancholic depression (2001) (29)
Neuropeptides : basics and perspectives (1990) (29)
Pituitary Neuropeptides and Behavior (1979) (28)
EFFECTS OF HYPOPHYSECTOMY ON RNA METABOLISM IN RAT BRAIN STEM (1970) (28)
CHAPTER 11 – Endorphin Influences on Learning and Memory (1981) (28)
Neurohypophyseal Hormones and Memory (1982) (27)
Structure and behavioural activity of peptides related to corticotrophin and lipotrophin (1980) (26)
Shock-prod burying test in rats: Autonomic and behavioral responses (1991) (26)
Time-related memory effects of vasopressin analogues in rats (1986) (26)
Changes in body temperature and water intake following intracerebral implantation of carbachol in rats (1967) (26)
Vasopressin fragment, AVP-(4–8), improves long-term and short-term memory in the hole board search task (1997) (26)
The interaction between γ-type endorphins and HLA class I antigens (1986) (26)
CHAPTER 19 – Vasopressin and Oxytocin in Learning and Memory (1981) (26)
Inhibition of the release of corticotrophin from the hypophysis by chlorpromazine. (1956) (25)
The ACTH-(4–9) analog ORG 2766 and desglycinamide9-(Arg8)-vasopressin reverse the retrograde amnesia induced by disrupting circadian rhythms in rats (1986) (24)
Autoradiographic studies with a behaviorally potent 3H-ACTH4–9 analog in the brain after intraventricular injection in rats (1980) (24)
Chapter 7 – The Physiology of the Neurohypophysial System and its Relation to Memory Processes (1977) (23)
Influence of classical and atypical neuroleptics on apomorphine‐induced behavioural changes and on extinction of a conditioned avoidance response (1983) (23)
Minor disturbances in central nervous system function in familial neurohypophysial diabetes insipidus (2006) (22)
Comparative effects of the ACTH 4–9 analogue (ORG 2766), ACTH 4–10 and [d-Phe7] ACTH 4ndash;10 on medial septal self-stimulation behaviour in rats (1982) (22)
HLA, AND THE RESPONSE TO TREATMENT WITH γ‐TYPE ENDORPHINS IN SCHIZOPHRENIA (1982) (22)
Histamine as an extremely potent releaser of vasopressin in the rat (1976) (22)
Retention of passive avoidance behavior in rats following α- and γ-endorphin administration: Effects of post-learning treatments (1981) (22)
(Des-tyrosine1)-gamma-endorphin in schizophrenia: Clinical, biochemical, and hormonal aspects (1981) (21)
Non-opiate β-endorphin fragments and dopamine—IV γ-type endorphins may control dopaminergic systems in the nucleus accumbens (1982) (21)
A long-lasting increase and decrease in synaptic excitability in the rat lateral septum are associated with high and low shuttle box performance, respectively (1995) (21)
Neuropeptides and Behaviour (1981) (21)
The Neuropeptide Story Geoffrey Harris Lecture, Budapest, Hungary, July 1994 (1997) (20)
Chapter 61: Neurohypophyseal hormone receptors: relation to behavior (1992) (20)
Antipsychotic Action of γ‐Type Endorphins: Animal and Human Studies (1986) (20)
Neurotrophic effects of ACTH/MSH neuropeptides. (1990) (20)
The neurohypophyseal hormones (1986) (20)
Selective attenuation of passive avoidance behaviour by microinjection of β-LPH62–77 and β-LPH66–77 into the nucleus accumbens in rats (1982) (20)
Pro‐opiomelanocortin (POMC) as Homeostatic Control System (1987) (20)
Effect of des-tyr1-γ-endorphin and des-tyr1-α-endorphin on α-MPT-induced catecholamine disappearance in rat brain nuclei: A dose-response study (1982) (20)
Peptides and adaptive behaviour (1980) (20)
Vagal Activation in Novelty-Induced Tachycardia During the Light Phase in the Rat (1998) (19)
The neuropeptide concept. (1984) (19)
THE ACTION OF Δ1 HYDROCORTISONE ON THE ANTIDIURETIC AND ADRENOCORTICOTROPIC RESPONSES TO NOXIOUS STIMULI1 (1959) (19)
Effects of ACTH4–10 on self-stimulation behavior in the rat (1980) (19)
An assay of corticotrophin-releasing principles in hypothalamic lesioned rats. (1961) (18)
Changes in heart rate and body temperature during passive avoidance behavior in rats (1990) (18)
Chapter 29 – Endorphins and schizophrenia (1992) (18)
Effect of vasopressin, oxytocin and peptides derived from these hormones on field potential induced in lateral septum of rats by stimulation of the fimbria fornix (1986) (18)
The effects of dogfish MSH's and of corticotrophin-like intermediate lobe peptides (CLIP's) on avoidance behavior in rats (1975) (17)
Clinical, biochemical, and hormonal aspects of treatment with des-tyr1-gamma-endorphin in schizophrenia (1984) (17)
The role of the pituitary adrenal system hormones in active avoidance conditioning (1972) (17)
Hypothalamic and pituitary peptide hormones and the central nervous system: With special references to the neurochemical effects of ACTH (1976) (17)
Changes in excitability of the theta activity generating substrate by ACTH 4–10 in the rat (1976) (17)
The Inhibitory Effect of ACTH 1-10 on Extinction of a Conditioned Avoidance Response: Its Independence of Thyroid Function (1968) (16)
Neuroleptic-Like and Antipsychotic Effects of γ-Type Endorphins (1981) (16)
β-endorphin and related peptides suppress phorbol myristate acetate-induced respiratory burst in human polymorphonuclear leukocytes (1989) (16)
Neuropeptides and psychopathology (1982) (16)
Analysis of the effect of progesterone on avoidance behavior (1973) (16)
Brain Peptides and Psychoactive Drug Effects (1981) (15)
Effect of adrenocorticotrophic and growth hormones on aldosterone production and plasma renin activity in chronically hypophysectomized sodium-deficient rats. (1970) (15)
The effect of corticotropin on the formation of corticosteroids in vitro. (1961) (15)
Barrel rotation induced by central arginine8-vasopressin treatment: Involvement of neurohypophyseal peptide receptors (1994) (15)
ACTH release during passive avoidance behavior (1977) (15)
THE ROLE OF THE POSTERIOR PITUITARY AND ITS PEPTIDES ON THE MAINTENANCE OF CONDITIONED AVOIDANCE BEHAVIOUR (1973) (14)
Proteolytic conversion of arginine-vasotocin by synaptic membranes from rat and chicken brain (1983) (14)
Hormonal influences on motivational, learning and memory processes (1976) (14)
Effects of β-endorphin fragments on plasma levels of vasopressin (1981) (14)
Hypothalamic neuropeptides and memory (2005) (14)
Structure-activity studies with ACTH/α-MSH fragments on corticosteroid secretion of isolated zona glomerulosa and fasciculata cells (1985) (14)
Pituitary-Adrenal Hormones and Behavior (1971) (14)
Vasopressin micro‐injections into the nucleus tractus solitarii decrease heart rate and blood pressure in anaesthetized rats (1988) (14)
Disturbed hypothalamic blood flow autoregulation in the rat following hypophysectomy: a role of pituitary β-endorphin? (1990) (13)
Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats: A.M. Ernst. Psychopharmacologia (Berl.) 10, 316–323 (1967) (2005) (13)
The Impact of Mild Emotional Stress Induced by the Passive Avoidance Procedure on Immune Reactivity (1987) (13)
γ-Type endorphins: Neurolepticum-like and antipsychotic action (1985) (13)
Pituitary peptides as modulators of neural functioning (1977) (12)
Mechanisms of action of behaviorally active ACTH like peptides (1981) (12)
Selective interference of ACTH4–10 with discriminative responding based on the narcotic cue (1978) (12)
Pituitary peptides on motivational, learning and memory processes (1975) (12)
Central Vasopressin Impairs the Baroreceptor Heart Rate Reflex in Conscious Rats (1990) (12)
Biotelemetry: Adjustment of a telemetry system for simultaneous measurements of acute heart rate changes and behavioral events in unrestrained rats (1993) (11)
On the Mechanism of ACTH Release (1964) (11)
Effects of β-endorphin and its fragments on inhibitory avoidance behavior in rats (1983) (11)
Microinjection of vasopressin and two related peptides into the amygdala: enhancing effect on local dopamine neurotransmission (1984) (10)
The influence of β-LPH fragments on α-MSH release: The involvement of a dopaminergic system (1981) (10)
Behavioral effects of the β-endorphin fragment 2–9 (1982) (10)
γ-Endorphin and schizophrenia: Amino acid composition of γ-endorphin and nucleotide sequence of γ-endorphin cDNA from pituitary glands of schizophrenic patients (1986) (10)
Neuropeptides: Animal behaviour and human psychopathology (2004) (10)
Further evidence for a dissociation of peripheral and central effects of vasopressin (1985) (10)
Peptide hormones and neuropeptides: birds of a feather (2000) (10)
Melanotropins as Neuropeptides (1993) (10)
Effects of environmental stimuli on immunoreactivity: Further studies on passive avoidance behavior (1989) (10)
Hypothalamic blood flow autoregulation remains unaltered following surgical and pharmacological blockade of central vasopressin (1991) (9)
Differential effects of DGAVP on acquisition and extinction of active avoidance behavior (1991) (9)
CHAPTER 18 – Vasopressin, Oxytocin, and Dependence on Opiates (1981) (9)
Influence of vasopressin and of a crude CRF preparation on pituitary ACTH-release in posterior-lobectomized rats. (1968) (9)
Vasopressin, vasopressin fragments and a C-terminal peptide of the vasopressin precursor share cardiovascular effects when microinjected into the nucleus tractus solitarii (1989) (8)
Influence of centrally administered α- and γ2-melanocyte-stimulating hormone on hypothalamic blood flow autoregulation in the rat (1987) (7)
γ-Type Endorphins and Schizophrenia (1981) (7)
Melanocortins, neural plasticity and aging (1986) (7)
CNS effects of ACTH, MSH, and opioid peptides (1986) (7)
Differential effects of ACTH4–10, DG-AVP, and DG-OXT on heart rate and passive avoidance behavior in rats (1992) (7)
ACTH-Induced lipolysis in rat adipocytes: Structure-activity relationships (1978) (7)
Neurohypophyseal Hormones and Behavior (1977) (7)
METABOLITES OF ARGININE-VASOPRESSIN AND OXYTOCIN ARE HIGHLY POTENT NEUROPEPTIDES IN THE BRAIN (1983) (7)
γ ‐Melanotropin and Brain Function (2008) (7)
Functional existence of a vasopressin V2 receptor subtype In the central nervous system (1990) (7)
Effect of hypothalamic lesions and hypophysectomy on corticoid production in vitro and on adrenal weight in rats. (1961) (7)
Influence of substance P and fragments on passive avoidance behavior (1984) (6)
Dissociation between Antidiuretic and Vasopressor Activity in Rat Posterior Pituitaries on Incubation in vitro (1966) (6)
NEUROPEPTIDES IN NORMAL AND ABNORMAL BEHAVIOR (1981) (6)
Alterations of β-endorphin-like immunoreactivity in CSF following behavioral training using a passive avoidance procedure (1996) (6)
Memory effects of arginine-vasopressin (AVP) and oxytocin (OXT): Structural requirements (1978) (6)
Non-opiate β-endorphin fragments and dopamine—V γ-type endorphins and prolactin secretion in rats (1982) (6)
Naloxone-like influence of TRH and ACTH-(4–7) on hypothalamic blood flow autoregulation in the rat (1988) (6)
HYPOTHALAMO-NEUROHYPOPHYSEAL HORMONE EFFECTS ON MEMORY AND RELATED FUNCTIONS IN THE RAT (1977) (6)
EFFECTS OF VARIOUS PEPTIDES ON ALDOSTERONE PRODUCTION OF SODIUM DEFICIENT RATS (1968) (6)
Cardiovascular effects of increasing sodium chloride concentrations microinjected into the nucleus tractus solitarii of the rat (1989) (5)
Impaired development of tolerance to morphine analgesia in rats with hereditary diabetes insipidus (2004) (5)
Neuroleptic‐like Activity and Antipsychotic Action of Cholecystokinin‐related Peptides (1985) (5)
THE EFFECT OF AUTONOMIC BLOCKADE ON THE RELEASE OF CORTICOTROPHIN FROM THE HYPOPHYSIS, AS INDUCED BY A HYPOTHALAMUS EXTRACT (1957) (5)
Pro-opio(melano)cortin and brain homeostasis. (1982) (5)
Neuropeptides and Functional Recovery after Brain Damage (1985) (4)
The influence of ascorbic acid on the glycogen content of the liver of normal and adrenalectomized rats exposed to cold. (1953) (4)
Pituitary stalk section transiently impairs the acquisition of shuttle box avoidance behavior (1983) (4)
Epithelium‐dependent potentiation of anaphylactic contractions by β‐endorphin in tracheae isolated from actively sensitized guinea‐pigs (1991) (4)
Neuroendocrine Regulation of Learning and Memory (2000) (4)
Simultaneous Occurrence of Barrel Rotation and Hypothermia in Rats Following Central Injection of AVP (1993) (4)
Corticotrophin-releasing action of adrenaline, serotonin and pitressin (2005) (3)
ACTH, structure activity and nervous system effects (1984) (3)
Behavioural effects of neuropeptides related to ß-LPH (1978) (3)
Drug effects on neuroendocrine regulation; Proceedings of the International Symposium, Snowmass-at-Aspen, Colo., July 17-19, 1972 (1973) (3)
THE INFLUENCE OF PACATAL ON THE CORTICOTROPHIN-RELEASING ACTIVITY OF THE HYPOPHYSIS (1958) (3)
Vasopressin(1–8) (des-glycinamide9-[Arg8]Vasopressin) is an endogenous peptide present in rat plasma (1991) (3)
Pro-opiomelanocortin and behavioral homeostasis. (1988) (3)
Neuropeptides as psychotropic drugs. (1992) (3)
The importance of vasopressin in memory (1984) (3)
Neuroendocrine Aspects of Learning and Memory Processes (1989) (3)
THE BLOCKING ACTION OF DEXAMETHASONE ON PITUITARY ACTH RELEASE (1962) (2)
Neuropeptides in the treatment of nervous system lesions (1991) (2)
Neuropeptides and brain function (1987) (2)
Pituitary Peptides and Adaptive Behavior (1978) (2)
Behavioral profile of vasopressin deficient rats (brattleboro strain) as assessed in open field and in appetitively and aversively motivated behavioral test situations (1986) (2)
Cellular and molecular bases of neuroendocrine processes (1976) (2)
Neuropeptides and Affective Disorders (1989) (1)
THE EFFECT OF PIG PITUITARY ACTH FRACTIONS ON DIFFERENT PARAMETERS OF ADRENOCORTICAL ACTIVITY (1963) (1)
Independence of the thyroid and adrenal gland in potassium thiocyanate (KCNS) induced hypotension in rats. (1966) (1)
Behavioural Effects of Pituitary Hormones (1981) (1)
Rapid conversion of a homocystine-containing peptide into its corresponding 11CH3-labeled methionine sulfone analogue. PET experiments with H-[S-11CH3]Met(O2)-Glu-His-Phe-D-Lys-Phe-OH (1989) (1)
Memory effects of vasopressin (AVP) and oxytocin (OXT): Localization of their sites of action (1978) (1)
The Effect of Autonomic Blockade on the ACTH-Release from the Pituitary, as Induced by a Hypothalamus Extract (1958) (1)
Failure to replicate Dissociation between Antidiuretic and Vasopressor Activity in Rat Posterior Pituitaries in vitro (1969) (1)
γ-Endorphin with Deviant Biological Activity: A Molecular Marker for Schizophrenia? (1989) (1)
Pharmacological bases of psychoneuroendocrinology: preclinical assessment of clinical facts (1980) (1)
Endorfinen en hun betekenis voor de psychopathologie (1979) (1)
Behavioral aspects of brain aging: the role of neurotrophic peptides (1984) (1)
POSSIBLE ROLE OF THE PITUITARY IN THE REGULATION OF ALDOSTERONE SECRETION IN THE RAT (1967) (1)
Opposite interactions between α- and β-endorphin fragments with dopamine mediated responses on the rat rectum in vitro (1982) (1)
Behavioral Effects of Prolactin: The Involvement of Brain Dopamine (1983) (1)
Interaction Between the Central Nervous System and the Immune System: The Influence of a Short and Mild Emotional Stress on the Proliferative Response of Rat Spleen Cells (1986) (1)
Pituitary peptides and conditioned avoidance behaviour: studies on the sit of action of vasopressin and ACTH4–10 (1974) (1)
Contraception in the year 2001 : proceedings of an Excerpta Medica Foundation symposium held at the Royal Netherlands Academy of Sciences and Letters, Amsterdam, 2nd-3rd October 1986 (1989) (1)
Behavioral Effects of β-Endorphin Fragments (1981) (1)
The significance of vasopressin (ADH) for the release of corticotropin from the adenohypophysis (2005) (1)
The effect of γ-type endorphins on α-MSH relase in the rat (1985) (1)
Is conditioned immunosuppression an adequate research strategy? (1985) (1)
THE ROLE OF MONOAMINERGIC PATHWAYS IN THE MEMORY EFFECTS OF VASOPRESSIN (1980) (0)
ENDOCRINOLOGY: THE EFFECT OF AUTONOMIC BLOCKADE ON THE RELEASE OF CORTICOTROPHIN FROM THE HYPOPHYSIS, AS INDUCED BY A HYPOTHALAMUS EXTRACT (1957) (0)
Analogifremgangsmaade for the preparation of tetra-, penta-, hexa- or heptapeptides or functional derivatives thereof (1977) (0)
Abstracts of papers pharmacological meeting (2005) (0)
Discussion to “Stress and the brain” by Isabella Heuser and Claas-Hinrich Lammers and “Stress and aging: theoretical and empirical challenges for interdisciplinary research” by Jacqui Smith (2003) (0)
Behavioral changes in short-term and long term hyperprolacinaemic rats (1983) (0)
918 – NEUROHYPOPHYSEAL HORMONES AND HEROIN SELF-ADMINISTRATION (1978) (0)
Analogifremgangsmaade for producing an ACTH-derivative containing 10-21 amino acid residues, or pharmacologically acceptable salts or metal complexes thereof (1977) (0)
ACTH-like neuropeptides as potential psychoactive and neuroactive drugs (1984) (0)
Abstracts of Dutch doctoral theses (2005) (0)
Brain aging and plasticity: behavioral aspects (1985) (0)
Effects of vasopressin-related peptides on electrical self-stimulation behaviour of rats (1986) (0)
Progress in psychoneuroendocrinology : proceedings of the XI congress of the International Society of Psychoneuroendocrinology held in Florence, Italy, 16-20 June, 1980 (1980) (0)
Substances re~bling C-terminal vas~in fragla~ Me~t in the brain b~ not in the pituitary g~d (1984) (0)
β-Endorphin modulates anaphylactic contractions of tracheae isolated from actively sensitized guinea pigs (1990) (0)
Hypothalamic control of aldosterone secretion: effect of vasopressin and growth hormone on aldosterone production in the sodium deficient rat with different hypothalamic lesions (1973) (0)
EFECCT OF POTASSIUM THIOCYANATE (KCNS) ON BLOOD PRESSURE AND THYROID FUNCTION IN THE ALBINO RAT (1965) (0)
494 – PITUITARY HORMONES ON MOTIVATIONAL, LEARNING AND MEMORY PROCESSES (1977) (0)
Abstracts of lectures symposium disposition and delivery of peptide drugs (1988) (0)
Central nervous system functions in familial neurohypophysial diabetes insipidus (2004) (0)
Chromatographical analysis of endorphin-like immunoreactivity in human peripheral blood leukocytes (1990) (0)
ACTH/MSH neuropeptides, behaviour and neurological diseases (1989) (0)
EFFECTS OF a-ENDORPHIN, fl-ENDORPHIN AND (DES-TYR1)-y-ENDOR-PHIN ON et-MPT-INDUCED CATECHOLAMINE DISAPPEARANCE IN DISCRETE REGIONS OF THE RAT BRAIN DIRK H. G. VERSTEEG, E. RONALD DE KLOET and DAVID DE WIED (2002) (0)
Scientific meeting of the Netherlands Society of Child Neurology held in Heeze, 7th of April 1989 Treatment of hypsarrhythmia with non-depot ACTH-(1–24) (1989) (0)
VASOPRESSIN AND MEMORY IN MAN (1984) (0)
Hypertension, brain catecholamines, and peptides : proceedings of the symposium held at the Rudolf Magnus Institute, Utrecht, the Netherlands, 19 October 1988 (1989) (0)
ACTH AND RELATED PEPTIDES AS PSYCHOACTIVE AND NEUROACTIVE DRUGS (1986) (0)
Nα-acetyl-γ-endorphin is an endogenous non-opioid neuropeptide with behavioural activity (1983) (0)
Preface (1997) (0)
Behavioral actions of corticotropin-releasing factor (1985) (0)
1367 – SELF-ADMINISTRATION OF DRUGS IN RATS: DOSE-RESPONSE STUDIES (1977) (0)
The effect of corticotropin releasing factor on heart rate, body temperature and behavior in rats (1990) (0)
Gonadal Hormones and Heart Rate as an Acute Emotional Stress Response (1987) (0)
Interaction Between HLA Class I Antigens and γ -Endorphin (1984) (0)
HORMONAL AND NEURONAL PEPTIDES AND BEHAVIOR (1983) (0)
Printed in the U.S.A. LEVELS OF ARGININE-VASOPRESSIN IN CEREBROSPINAL FLUID DURING PASSIVE AVOIDANCE BEHAVIOR IN RATS (2002) (0)
Neurochemical and psychopharmacological approaches to cognitive enhancers: Preface (1997) (0)
Clinical, Biochemical, and Hormonal Aspects of Treat- ment With Des-Tyrl-Gamma-Endorphin in Schizo- phrenia (2002) (0)
P.1.072 Plasma arginine vasopressin and motor activity in patients with major depression and in healthy controls (1996) (0)
Psycho Pharmacologically active peptides and peptide derivatives and process for their preparation (1977) (0)
Cognition Disturbances in Psychiatry: Neurobiology and Treatment (In memory of David de Wied), May 15-16, 2009, Catalina, Italy. (2010) (0)
In memoriam Béla Bohus 1936–2000 (2009) (0)
Plasma Arginine Vasopressin Major Depression and Motor Activity in (1998) (0)
Pharmacology and endrocrinology of septal driving of the hippocampal theta rhythm in the free-moving rat N. McNaughton, J. A. Gray and D. T. D. James — Department of Experimental Psychology, University of Oxford, Oxford (Great Britain) (1975) (0)
DISCUSSION: EFFECT OF HYPOTHALAMIC LESIONS (1964) (0)
Biochemical correlates of behavioral effects of peptides in the central nervous system (1974) (0)
ACTH and brain aging: A possible role for neurotrophic peptides (1984) (0)
Neuropeptides, brain and behavior (1976) (0)
Abstracts of papers pharmacological meeting (2005) (0)
NEUROTROPHIC EFFECTS OF ACTHIMSH NEUROPEPTIDES (2009) (0)
Analogifremgangsmaade for the preparation of gamma-endorphin analogs or peptide derivatives hexadekapeptider (1979) (0)

This paper list is powered by the following services:

Other Resources About David de Wied

en.wikipedia.org

What Schools Are Affiliated With David de Wied?

David de Wied is affiliated with the following schools: